SLC18A2 and Parkinson disease: Apart from DA depletion, a profound reduction in specific neurochemical markers such as tyrosine hydrolase (TH), DA transporter (DAT), and vesicular monoamine transporter 2 (VMAT2) has been reported in PD [4, 5].